Impact of the Combined Immunosuppressive Therapy on Different Mortality Score Groups in Amyopathic Dermatomyositis-Associated Interstitial Lung Disease and the Problem of Sample Splitting

Chest. 2021 Feb;159(2):882-883. doi: 10.1016/j.chest.2020.07.099.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Dermatomyositis* / complications
  • Dermatomyositis* / drug therapy
  • Humans
  • Immunosuppression Therapy
  • Immunosuppressive Agents / therapeutic use
  • Lung Diseases, Interstitial* / drug therapy
  • Lung Diseases, Interstitial* / etiology

Substances

  • Immunosuppressive Agents

Supplementary concepts

  • Amyopathic dermatomyositis